The Lone Star Pharmacist - September 2018
- No tags were found...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Volume 4 • <strong>September</strong> <strong>2018</strong> • Number 1<br />
<strong>The</strong> Official Publication of the Texas Society of Health-System <strong>Pharmacist</strong>s – Research & Education Foundation<br />
Quarterly publication direct mailed to more than 41,000 <strong>Pharmacist</strong>s, Technicians,<br />
Students and Members of TSHP.<br />
TSHP President’s Letter<br />
Texas Report on the<br />
ASHP 70th House of<br />
Delegates<br />
<strong>The</strong> House of Delegates<br />
(HOD) is the ultimate<br />
authority over ASHP<br />
professional policies,<br />
which express the Society’s<br />
stance on important issues<br />
related to health-system<br />
pharmacy practice and<br />
medication use in society. 1<br />
<strong>The</strong> sum of the knowledge,<br />
values, ethics, ideals, and<br />
aspirations of health-system<br />
current resident or<br />
Tammy Cohen,<br />
PharmD, MS, FACHE,<br />
FASHP, FTSHP<br />
pharmacists is reflected in the collective body of ASHP<br />
professional policies. Members can take pride in this<br />
core strength of ASHP and should be aware of the<br />
high expectations that surround their deliberations on<br />
the latest issues. 2<br />
ASHP’s democratic policy process allows for<br />
representation from all 50 states. Texas is allotted<br />
six seats in the ASHP HOD. <strong>The</strong> Texas delegates<br />
are elected by those that are both TSHP and ASHP<br />
members and for <strong>2018</strong> included Tammy Cohen,<br />
Shane Greene, Katie Morneau, Sidney Phillips, Ryan<br />
Roux, and Jeff Wagner. Emily Alexander served as<br />
the alternate delegate. Joining the Texas delegation<br />
include ASHP Past Presidents Diane Ginsburg and<br />
Roger Anderson, and ASHP Section Chair Tricia<br />
Meyer, who are also from Texas.<br />
<strong>The</strong> annual ASHP HOD Delegate cycle starts in<br />
January when the delegates are seated, followed by<br />
orientation and the first virtual house meeting held in<br />
March. <strong>The</strong> regional delegate conferences are held<br />
in April and May, were delegates gather to discuss<br />
the proposed professional policies before the June<br />
House, potential amendments, and areas of unmet<br />
policy need. <strong>The</strong> live HOD meeting is held at the<br />
Non-Profit Org.<br />
U.S. Postage Paid<br />
Princeton, MN<br />
Permit No. 14<br />
ASHP Summer Meeting, which was in Denver this<br />
year. <strong>The</strong> second virtual HOD meeting is to be held<br />
in November.<br />
<strong>The</strong> annual ASHP HOD Delegate cycle changed<br />
in 2015 to include virtual meetings. <strong>The</strong> virtual<br />
meetings are held in the spring and fall, to provide<br />
an opportunity for delegates to debate and vote on<br />
policy recommendations in a timelier fashion, making<br />
the ASHP policy process more responsive. 1<br />
<strong>The</strong> 1st Virtual HOD meeting was held March<br />
16-23, <strong>2018</strong>. <strong>The</strong> delegates voted on voted on<br />
ten policy recommendations. Delegates approved<br />
nine recommendations by more than 85 percent,<br />
the threshold set by the Board Task Force on<br />
Organizational Structure for final approval and<br />
declined one recommendation. <strong>The</strong> approved policies<br />
are as follows: Unit Dose Packaging Availability;<br />
Gene <strong>The</strong>rapy; Medications Derived from Biologic<br />
Sources; Role of <strong>Pharmacist</strong>s and Business Leaders<br />
in Health Care Services and Policies; Confidence<br />
in the U.S. Drug Approval and Regulatory Process;<br />
Size, Color, and Shape of Drug Products; Drug<br />
Dosing in Conditions that Modify Pharmacokinetics<br />
or Pharmacodynamics; Appropriate Dosing of<br />
Medications in Patient Populations with Unique Needs;<br />
and DEA Scheduling of Hydrocodone Combination<br />
Products. <strong>The</strong> policy recommendation that did not<br />
achieve the 85 percent threshold for approval was<br />
Pharmacy Practice Training Models, which was later<br />
reviewed and edited at the June meeting.<br />
Details can be found at http://bit.ly/2JbYFkq.<br />
<strong>The</strong> 70th HOD meeting was held at the ASHP<br />
Summer Meeting June 2-6, <strong>2018</strong> in Denver, CO.<br />
<strong>The</strong> Delegates attended the open forum, multiple<br />
caucuses, and delegate meetings. <strong>The</strong> delegates<br />
reviewed and commented on 31 policies and<br />
resolutions and several were amended through the<br />
process. On Day Two of the HOD, Texas delegates<br />
submitted two recommendations. Texas Delegate<br />
Inside...<br />
Foundation Welcomes Next President.............. 2<br />
TSHP <strong>2018</strong> Annual Seminar..................... 3<br />
<strong>The</strong> Community is Advancing. Grow with Us ......... 3<br />
TSHP Career Center........................... 4<br />
Pharmacy Management Corner .................. 4<br />
TSHP R & E Foundation Contribution Form .......... 4<br />
Katie Morneau entered a recommendation regarding<br />
active involvement in organizations and Texas<br />
Delegate Tammy Cohen entered a recommendation<br />
on <strong>Pharmacist</strong> involvement in the post-acute setting.<br />
Both recommendations will be taken back to ASHP<br />
for review, processing and potential assignment to a<br />
council. In addition to policy work, the HOD held the<br />
election for the <strong>2018</strong>-2021 chair of the HOD. Casey<br />
White from Tennessee was elected and installed<br />
at the conclusion of the meeting and will serve as<br />
the chair for the upcoming three years. Casey has<br />
been a delegate for Tennessee for the last ten years<br />
and worked with Texas delegates over the years on<br />
various policy recommendations.<br />
Details can be found at www.ashp.org/House-of-<br />
Delegates.<br />
“ASHP House of Delegates”. American Society of<br />
Health System <strong>Pharmacist</strong>s. Web Wed 05 July<br />
2017.<br />
Why Professional Policies Matter. Am J Health-Syst<br />
Pharm—Vol 66. Jun 1, 2009.<br />
Alcalde Save the Date ......................... 4<br />
TSHP Calendar of Events ....................... 5<br />
TSHP Announces Officer Election Results. ........... 5<br />
Happy Pharmacy Month. . . . . . . . . . . . . . . . . . . . . . . . 5<br />
New Practitioner Corner. ....................... 6<br />
FDA New Drugs May ‘18 -July‘18. ................ 7
Page 2 <strong>September</strong> <strong>2018</strong> <strong>The</strong> <strong>Lone</strong> <strong>Star</strong> <strong>Pharmacist</strong><br />
Foundation Welcomes<br />
Next President<br />
In April, the TSHP<br />
Research & Education<br />
Foundation installed their<br />
next President, Rebecca<br />
B. Sleeper-Irons, PharmD,<br />
FCCP, FASCP, BCPS.<br />
Rebecca’s is currently the<br />
Professor and Associate<br />
Dean of Curriculum at Texas<br />
Tech University Health<br />
Science Center School of<br />
Pharmacy in Lubbock, TX.<br />
As she begins her term,<br />
and on behalf of the TSHP<br />
R&E Foundation Board of<br />
Rebecca B. Sleeper-<br />
Irons, PharmD, FCCP,<br />
FASCP, BCPS<br />
Directors, she would like to extend a sincere thank<br />
you for your continued support of the Foundation and<br />
for your belief in the future of pharmacy in Texas.<br />
TSHP Research & Education<br />
Foundation Board of Directors<br />
Officers<br />
President<br />
Rebecca B. Sleeper-Irons, PharmD,<br />
FCCP, FASCP, BCPS<br />
Professor and Associate Dean of Curriculum,<br />
Texas Tech University School of Pharmacy<br />
Treasurer<br />
Bradi L. Frei, PharmD, MSc, BCOP, BCPS<br />
Associate Professor, University of the Incarnate<br />
Word, Feik School of Pharmacy<br />
Oncology Clinical Specialist, University of<br />
Texas Health Science Center at San Antonio<br />
Secretary<br />
Kimberly Putney, PharmD, MPH<br />
Manager, Clinical Pharmacy, Baylor<br />
St. Luke’s Medical Center<br />
Director (Non-<strong>Pharmacist</strong>)<br />
Beth Walgren, MBA<br />
Ipsen, Oncology Regional Sales Director<br />
Directors<br />
Lourdes Cuellar, MS, RPh<br />
Bonnie Dugie, PharmD, MBA, MTM<br />
Larry Egle, PharmD, MS, MBA<br />
Diane Kretschmer, RPh, PharmD<br />
Stewart Wirebaugh, PharmD<br />
Butch Habeger, RPh, MBA, FASHP, FTSHP<br />
Fred Mullin, MBA, RPh<br />
Alcalde, Executive Director<br />
Linda S. Albrecht, MBA, RPh, FASHP, FTSHP<br />
TSHP Executive Committee Liaison<br />
Steven Knight, PharmD, BCPS, RPh, CMTM<br />
Contact the TSHP Office for information<br />
about upcoming issues or to suggest<br />
content ideas. Contact TSHP at<br />
512-906-0546 or at<br />
Jenni.Peters@tshp.org.<br />
For advertising rates and information, please<br />
contact Arthur L. Davis Publishing Agency, Inc.,<br />
517 Washington Street, PO Box 216, Cedar Falls,<br />
Iowa 50613, (800) 626-4081, sales@aldpub.com.<br />
TSHP – R&E Foundation and the Arthur L. Davis<br />
Publishing Agency, Inc. reserve the right to reject any<br />
advertisement. Responsibility for errors in advertising is<br />
limited to corrections in the next issue or refund of price<br />
of advertisement.<br />
Acceptance of advertising does not imply<br />
endorsement or approval by the Texas Society of<br />
Health-System <strong>Pharmacist</strong>s – Research & Education<br />
Foundation of products advertised, the advertisers,<br />
or the claims made. Rejection of an advertisement<br />
does not imply a product offered for advertising is<br />
without merit, or that the manufacturer lacks integrity,<br />
or that this association disapproves of the product<br />
or its use. TSHP – R&E Foundation and the Arthur L.<br />
Davis Publishing Agency, Inc. shall not be held liable<br />
for any consequences resulting from purchase or use<br />
of an advertiser’s product. Articles appearing in this<br />
publication express the opinions of the authors; they<br />
do not necessarily reflect views of the staff, board, or<br />
membership of TSHP – R&E Foundation or those of<br />
the national or local associations.<br />
<strong>The</strong> Official Publication of the Texas Society of Health-System <strong>Pharmacist</strong>s – R&E Foundation
<strong>The</strong> <strong>Lone</strong> <strong>Star</strong> <strong>Pharmacist</strong> <strong>September</strong> <strong>2018</strong> Page 3<br />
<strong>The</strong> Community is Advancing. Grow with Us.<br />
A message from the Chair of TSHP’s Membership Development Council<br />
It’s hard to believe<br />
Summer has come and<br />
gone. It seems like the<br />
TSHP Annual Seminar<br />
in <strong>The</strong> Woodlands was<br />
only yesterday! Hopefully<br />
everyone had a great<br />
summer. During this time,<br />
TSHP has been working<br />
hard post-seminar, gearing<br />
up for <strong>2018</strong>-19 with new<br />
initiatives and begun Jesse Chaffino<br />
preparation for next year’s<br />
event in Frisco, TX. As successful as this past April<br />
was, no doubt next year will be bigger and better!<br />
With Fall upon us, do not forget “Pharmacy Month”<br />
is around the corner. Each year, October celebrates<br />
Pharmacy Week (Oct 14-20), as well as National<br />
Pharmacy Technicians Day (Oct 16). TSHP celebrates<br />
by acknowledging and recognizing the hard work of<br />
our members and pharmacy professionals across the<br />
state. Be sure to follow us on Facebook (@TexasSHP),<br />
Twitter (@TSHP_org), and LinkedIn to see what your<br />
colleagues around the state are up to. It’s all about<br />
being #PharmacyStrong!<br />
“Pharmacy Month” is also a time where we tie<br />
in one of our largest membership drives of the year.<br />
With the TSHP Local Chapter Challenge competition<br />
in full swing, this is an excellent opportunity to support<br />
your local chapter by becoming a member and help<br />
your Chapter gain bragging rights! Who will unseat<br />
the reigning champs, El Paso Area SHP? Or will they<br />
repeat as “Best of TSHP” for Membership Growth?<br />
If you are already a member of TSHP, the best thing<br />
you can do is refer a friend! Refer 5 new members<br />
and receive $25 off you next membership renewal<br />
through the Refer-A-Friend Program. Visit www.tshp.<br />
org/referral for details.<br />
Community members already know the benefits<br />
of staying involved with TSHP — networking<br />
opportunities, legislative support, local chapter<br />
activities, scholarships (students, technicians, &<br />
residents), research grants, mentoring, and many other<br />
member-only benefits. <strong>The</strong>re’s something for everyone!<br />
Plus, members receive up to $100 off Annual Seminar<br />
registration. Visit www.TSHP.org to learn about all<br />
Support the<br />
future of<br />
Pharmacy<br />
DONATE<br />
TODAY<br />
the benefits, resources, and most importantly, how to<br />
JOIN!! Grow with us as we launch new benefits and<br />
services this year and in the coming years!<br />
As Membership Council Chair and on behalf of<br />
your TSHP leadership team, I would like to thank our<br />
members for being a part of our growing Society!<br />
More than ever, TSHP is working hard to give back<br />
to members and we are constantly striving to enhance<br />
member benefits. It is also about recognizing everyone<br />
in the pharmacy profession, and this October, we<br />
celebrate your hard work and contributions to patient<br />
care. Thank you for all you do!<br />
Until next time, enjoy football season! Go<br />
Cowboys*! We look forward to seeing many of you<br />
in December at ASHP Midyear in California for the<br />
Texas Reception! And don’t forget, with your help<br />
through the TSHP community, we truly are Pharmacy<br />
Leaders. Transforming Patient Care.<br />
*TSHP is not affiliated with any one professional sports team.<br />
Fandom expressed in this article is the opinion of the current<br />
Membership Chair and author of this article, Jesse Chaffino.<br />
TSHP TSHP R&E R&E Foundation<br />
Foundation<br />
Supporting<br />
Supporting<br />
Texas<br />
Texas<br />
pharmacy<br />
pharmacy<br />
students<br />
students<br />
through<br />
through<br />
scholarships<br />
scholarships since<br />
since<br />
1977<br />
1977<br />
<strong>The</strong> Official Publication of the Texas Society of Health-System <strong>Pharmacist</strong>s – R&E Foundation
Page 4 <strong>September</strong> <strong>2018</strong> <strong>The</strong> <strong>Lone</strong> <strong>Star</strong> <strong>Pharmacist</strong><br />
Pharmacy Management Corner<br />
“<br />
<strong>The</strong> Pharmacy Degree<br />
affords one the<br />
opportunity to pursue<br />
whatever one dreams.<br />
”<br />
I have shared this with<br />
future, current, and graduate<br />
pharmacy students over<br />
decades of mentorship. I<br />
share it with our pharmacy<br />
community in this, my first<br />
article highlighting the TSHP<br />
Pharmacy Management<br />
Section initiatives for <strong>2018</strong><br />
and 2019. It speaks to the<br />
Tony Palmer, RPh,<br />
DBA<br />
TSHP <strong>2018</strong>-<br />
2019 Pharmacy<br />
Management Section<br />
Chair<br />
Section’s passion to serve our membership and our<br />
profession.<br />
<strong>The</strong> TSHP Pharmacy Management Section<br />
Executive Committee engaged in a robust first<br />
planning meeting mid-June. <strong>The</strong> Section’s initiative for<br />
the design, in collaboration with the TSHP Education<br />
Council, of the management CE tracks for the 2019<br />
Annual Meeting is developing. <strong>The</strong> CE track will<br />
focus on enhancing the value of institutional clinical<br />
management practice covering a variety of topics. I<br />
invite you to check back as more to come on this in<br />
future issues.<br />
Working with the TSHP Membership Council,<br />
our Section, supports as an initiative, the TSHP<br />
goal to suggest new member benefits to elevate<br />
the value membership to our community. Employee<br />
engagement, clinical benchmarking best practices,<br />
measurement of clinical impact, and repositioning<br />
the pharmacist role were discussed by the Section<br />
Executive Committee during our first meeting. I ask<br />
the Section membership to email me tony.palmer@<br />
unthsc.edu or Kathryn Merkel our Section’s Chair-<br />
Elect at KGMerkel@ascension.org with suggested<br />
TSHP membership benefits that would assist you in<br />
your daily challenges.<br />
If you are interested or have questions/suggestions<br />
regarding our TSHP Pharmacy Management Section,<br />
please contact me or Kathryn. We look forward<br />
to working with our fellow Pharmacy Management<br />
professionals and the TSHP community.<br />
SAVE THE DATE<br />
April 10-11, 2019 | Frisco, TX<br />
www.tshp.org/alcalde<br />
TSHP<br />
TSHP<br />
Career Career Center Center<br />
Connecting Talent<br />
Connecting Talent<br />
with Opportunity<br />
with Opportunity<br />
www.tshp.org/cc<br />
www.tshp.org/cc<br />
Your support has impacted so many.<br />
Your continuted contribution<br />
will help many more.<br />
Since 1977, the TSHP R&E Foundation has been<br />
helping the future of pharmacy in Texas – students,<br />
practitioners, technicians, and leaders. With each<br />
passing year, the need increases.<br />
A student at a typical state-supported college of<br />
pharmacy pays:<br />
• $10,000 per semester for tuition and fees<br />
• An average of $250 per book<br />
• Approximately $1,200 per<br />
month for a dorm room<br />
• Not to mention transportation<br />
& living expenses<br />
Contribution to our scholarships make all the<br />
difference in a student’s life.<br />
<strong>The</strong> R&E Foundation asks for your support. Help<br />
someone in honor of those who helped you. We<br />
are all part of a profession that recognizes the<br />
need to nurture a strong pharmacy foundation for<br />
each other, our patients, and for the future of our<br />
profession.<br />
<strong>The</strong> Foundation supports more than scholarships.<br />
Through contributions to the R&E Administrative<br />
Fund, we fund research grants, the annual R&E<br />
Poster Competition and Clinical Skills & Disease<br />
State Management Competitions, as well as<br />
provide support for residency programs and the<br />
annual Alcalde Southwest Leadership Conference.<br />
We are proud to be able to gift thousands of<br />
dollars in scholarships and awards every year,<br />
thanks to you. Our strong future is supported<br />
entirely by pharmacists, technicians, and friends of<br />
pharmacy, like you, who honor the legacy of the<br />
pharmacy profession and its leaders.<br />
TSHP RESEARCH & EDUCATION<br />
FOUNDATION CONTRIBUTION FORM<br />
CONTRIBUTOR INFORMATION<br />
Name:_______________________________________<br />
Email:________________________________________<br />
Address:_____________________________________<br />
City/State/Zip:________________________________<br />
Phone:_______________________________________<br />
PLEDGE CONTRIBUTION<br />
I pledge $______________ per year, for______years.<br />
ONE-TIME CONTRIBUTION<br />
$1,000 $500 $250 $100<br />
$50 $25 $_______________<br />
MY CONTRIBUTION SHOULD SUPPORT:<br />
Paul & Beth Davis Administrative Fund<br />
(internship program, poster competition,<br />
& general operations)<br />
Other____________________________________<br />
PAYMENT INFORMATION:<br />
Enclosed<br />
Bill Me<br />
Makes checks payable to TSHP R&E Foundation<br />
Card #:______________________________________<br />
Exp:_________________________________________<br />
CVV: ________________________________________<br />
Billing Address:________________________________<br />
City/State/Zip:________________________________<br />
Name on Card________________________________<br />
Signature: ____________________________________<br />
or contribute online at<br />
www.tshp.org/donate<br />
<strong>The</strong> Official Publication of the Texas Society of Health-System <strong>Pharmacist</strong>s – R&E Foundation
<strong>The</strong> <strong>Lone</strong> <strong>Star</strong> <strong>Pharmacist</strong> <strong>September</strong> <strong>2018</strong> Page 5<br />
TSHP Calendar<br />
of Events<br />
<strong>September</strong> <strong>2018</strong><br />
All month Call for Presentations for Annual Seminar 2019<br />
All month<br />
<strong>September</strong> 15<br />
<strong>September</strong> 17<br />
October <strong>2018</strong><br />
All month<br />
October 20<br />
October 31<br />
November <strong>2018</strong><br />
All month<br />
November 2<br />
November 6<br />
November 18<br />
December <strong>2018</strong><br />
December 2<br />
December 2-6<br />
TSHP Journal article submissions accepted<br />
Central Texas Society of Health-System<br />
<strong>Pharmacist</strong>s (CTSHP) Seminar<br />
ASHP Texas Delegate Call for<br />
Nominations opens<br />
TSHP Journal article submissions accepted<br />
Austin Area Society of Health-System<br />
<strong>Pharmacist</strong>s (AASHP) Seminar<br />
CAB Bond Memorial Research<br />
Grant application closes<br />
TSHP Journal article submissions accepted<br />
UHCOP Residency Showcase<br />
TSBP Board Business Meeting – Austin, TX<br />
ASHP Texas Delegate Call for<br />
Nominations closes<br />
Texas Reception at ASHP Midyear<br />
ASHP Midyear – Anaheim, CA<br />
TSHP Announces Officer<br />
Election Results<br />
Sarah Lake-Wallace, MS, PharmD, FTSHP, has been<br />
elected the <strong>2018</strong>-19 TSHP President-Elect Designee. For<br />
the past three years, Sarah has been the pharmacy<br />
manager for TIRR Memorial Hermann in Houston. Sarah<br />
has served in many capacities for TSHP, including service<br />
as a council chair for multiple councils and as a clinical<br />
skills coordinator. Sarah also served on the R&E Foundation<br />
Board of Directors for nine years, serving as their president<br />
for her last two years on the board.<br />
Randy Martin, PharmD, BCCP has been elected as the<br />
<strong>2018</strong>-19 TSHP Treasurer-Elect. Randy is currently Associate<br />
Dean for Clinical Affairs at University of North Texas System<br />
College of Pharmacy, a Fellow for the Institute of Patient<br />
Safety, and an Associate Professor of Pharmacotherapy.<br />
Randy has been an active and involved member of TSHP<br />
since 2004, serving in three elected officer positions.<br />
Please join us in congratulating Sarah & Randy!<br />
We Make Filling Worker’s<br />
Comp Prescriptions<br />
More Profitable!<br />
We Are <strong>The</strong> New Workers’ Comp PBM,<br />
<strong>The</strong> Only PBM You Will Need!<br />
As your WC benefits management company,<br />
we will give you an easier, more transparent<br />
way to generate workers’ comp revenue.<br />
WCRX Services is a pharmacist-owned and<br />
operated company that truly understands<br />
your need for a simple & more profitable WC<br />
program in your pharmacy.<br />
• Generic: $10 dispensing fee & 10%<br />
markup above CMS-MAC pricing<br />
• Brand Name: $5 dispensing fee & 5%<br />
markup, above CMS-WAC pricing<br />
• Weekly automated reimbursements<br />
ACH/Direct deposit<br />
• Electronic claims submission<br />
• Suggested appeal measures for denied<br />
claims<br />
• Easy In/Easy Out agreement that can<br />
be canceled with no penalty. Audits<br />
only on demand by insurance carrier.<br />
• BIN: 015730/PCN/Group: Servrx1<br />
 Call NOW for more information! 844-WCR-XSVC (927-9782)<br />
www.workerscomprxservices.com<br />
<strong>The</strong> Official Publication of the Texas Society of Health-System <strong>Pharmacist</strong>s – R&E Foundation
Page 6 <strong>September</strong> <strong>2018</strong> <strong>The</strong> <strong>Lone</strong> <strong>Star</strong> <strong>Pharmacist</strong><br />
New Practitioner Corner<br />
Now’s the time to join the TSHP New Practitioner Section<br />
Hongmei Wang<br />
Justin Shanks<br />
Hongmei Wang, PharmD, PhD, BCPS<br />
and Justin Shanks, PharmD<br />
Are you a recent graduate in your first<br />
five years of practicing pharmacy?<br />
Are you looking for ways to advance your career?<br />
If so, we can help. As a member of the TSHP New<br />
Practitioner (NP) Section you have the opportunity<br />
to explore mentorship, learn skills & knowledge to<br />
tackle workplace challenges, expand your clinical<br />
competence, and develop leadership skills.<br />
New practitioners have unique needs, interests, and<br />
concerns that are often different from more experienced<br />
members of the profession. <strong>The</strong> objective of TSHP’s NP<br />
Section is to provide an avenue of support to assist<br />
with the many challenges that come with transitioning<br />
from a student to a practicing health-system or hospital<br />
pharmacist. <strong>The</strong> volunteer leadership of the TSHP<br />
New Practitioner Section Committee (NPSC) strives<br />
to serve TSHP and the members of the NP Section<br />
through several ongoing initiatives intended to enrich<br />
member experiences, benefits, continuing education,<br />
and volunteer opportunities. We are excited about the<br />
new initiatives launching this year and look forward<br />
to you taking advantage of them, as we strive to<br />
better serve you and the members of the TSHP New<br />
Practitioner Section!<br />
Do you feel like you are in over your<br />
head trying to advance your career?<br />
Learn how to potentially navigate some of these<br />
challenges through the TSHP Mentorship Program!<br />
Participation in the TSHP Mentorship Program is<br />
open to pharmacy students, new practitioner and<br />
pharmacist members. It is often considered one of<br />
the most valuable initiatives, as it benefits not only<br />
new practitioners but students and more experienced<br />
members alike. Volunteers from the NPSC match<br />
interested mentors with mentees based on practice<br />
area interest and location to facilitate a relationship<br />
that will hopefully continue to grow through the years.<br />
Mentees will learn from the wealth of experience of<br />
their mentor and the mentor will benefit from further<br />
developing their precepting and coaching skills with<br />
matched mentees of similar interests. Additionally,<br />
mentees will have direct access to their mentor’s tips,<br />
tricks, and best practices that they used to make their<br />
career both successful and rewarding. Helping shape<br />
the future of pharmacy in Texas!<br />
offering content that enriches new practitioner skills,<br />
as well as addressing other pertinent issues specific to<br />
our career stage. <strong>The</strong> NPSC actively seeks presenters<br />
for CE topics from both<br />
inside and outside of the<br />
TSHP membership and the<br />
new practitioner section.<br />
If you are interested<br />
in speaking at Annual<br />
Seminar or presenting/<br />
proposing a CE topic,<br />
please contacting us! We<br />
would like input from new<br />
practitioners on what CE<br />
topics are most pertinent<br />
to you, that you believe<br />
would benefit other new<br />
practitioners. Additionally,<br />
the NP section is in the development and planning<br />
process of potentially offering more online CE. We<br />
know practice can be overwhelming but learning<br />
through online CE exercises is one way to brush up<br />
on therapeutic topics and expand your knowledge<br />
base, another great opportunity for professional topic<br />
presentation and collaboration.<br />
Are you having trouble meeting colleagues that<br />
can help get you where you want to go?<br />
Our members have access to many networking<br />
opportunities to meet fellow new practitioners and<br />
practitioners, as well as TSHP members in leadership/<br />
management positions across the great state of Texas.<br />
<strong>The</strong> TSHP Annul Seminar is the largest gathering of<br />
health-system and hospital pharmacy professionals in<br />
Texas. <strong>The</strong> networking and social opportunities at the<br />
Annual Seminar may just be the single best resource<br />
for you to learn about opportunities you need to<br />
navigate up the career ladder.<br />
Looking for ways to supplement your CV or<br />
improve your teamwork and leadership skills?<br />
<strong>The</strong> New Practitioner Section offers many<br />
leadership opportunities to set yourself apart. All NP<br />
members are eligible to apply for an opportunity to<br />
serve on the New Practitioner Section Committee.<br />
This Committee consist of NPs from across Texas who<br />
meet and collaborate with local, state, and national<br />
leaders on our various initiatives designed to serve<br />
not only NPs, but all TSHP. One such initiative is our<br />
college outreach initiative where Committee members<br />
reach out to schools of pharmacy across the state<br />
to speak about opportunities within health-system and<br />
hospital pharmacy and current pharmacy issues. <strong>The</strong><br />
Why should I join TSHP New<br />
Practitioner Section?<br />
• Reduced membership dues the first<br />
five years following graduation<br />
• Discounted Annual Seminar registration<br />
• Leadership and career development<br />
• Networking/Mentorship/Menteeship<br />
• Publications/Speaker Opportunities<br />
presentations include information about the TSHP<br />
Annual Seminar, residencies, Mentorship Program,<br />
opportunities to serve within TSHP, and more! <strong>The</strong> NPSC<br />
encourages all interested<br />
new practitioners to get<br />
involved and consider<br />
applying for a position<br />
during the next Call for<br />
Volunteers in the spring.<br />
Additionally, we would<br />
encourage all practitioners<br />
to get involved with one of<br />
the many local chapters<br />
throughout Texas.<br />
This year, the NP Section<br />
has begun distributing<br />
a section newsletter<br />
and monthly brief. This<br />
newsletter includes clinical pearls, information about<br />
state and local events, accomplishments, membership<br />
testimonials, and much more! Members can look<br />
forward to continued editions of this communication<br />
to stay informed and involved. If you wish to receive<br />
this communication and are not a member, please visit<br />
www.tshp.org/join or contact one of the NP Section<br />
Chairs listed below.<br />
We are always looking for new ways to help our<br />
fellow new practitioners. <strong>The</strong> possibilities are endless<br />
and the level of commitment is totally up to you. <strong>The</strong><br />
important thing is to get involved. Help ensure your<br />
success and a rewarding career; join the TSHP New<br />
Practitioner Section TODAY!<br />
If you would like additional information, please feel<br />
free to contact us!<br />
Chair – Hongmei Wang (hongmei.wang@tsu.edu)<br />
Chair-Elect – Justin Shanks (jds117bus@gmail.com)<br />
Have you had difficulty continuing to strengthen<br />
your clinical practice or teaching skills since<br />
finishing pharmacy school or residency?<br />
<strong>The</strong> TSHP NPSC develops educational<br />
programming for the TSHP Annual Seminar, specifically<br />
aimed at polishing the skills of new practitioners.<br />
Annual Seminar CE is planned with the intent of<br />
<strong>The</strong> Official Publication of the Texas Society of Health-System <strong>Pharmacist</strong>s – R&E Foundation
<strong>The</strong> <strong>Lone</strong> <strong>Star</strong> <strong>Pharmacist</strong> <strong>September</strong> <strong>2018</strong> Page 7<br />
FDA New Drugs • May ‘18 - July ‘18<br />
Approval Date Drug Name Active Ingredients Submission Classification Review Priority ** Company<br />
5/4/<strong>2018</strong> PLENVUNDA #209381 ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; Type 2 - New Active Ingredient Standard SALIX PHARMS INC<br />
POTASSIUM CHLORIDE; SODIUM ASCORBATE;<br />
SODIUM CHLORIDE; SODIUM SULFATE<br />
5/15/<strong>2018</strong> LAMIVUDINE AND TENOFOVIR DISOPROXIL LAMIVUDINE; TENOFOVIR<br />
Type 5 - New Formulation or New Manufacturer Standard AUROBINDO PHARMA LTD<br />
FUMARATENDA #022344<br />
DISOPROXIL FUMARATE<br />
5/15/<strong>2018</strong> RETACRITBLA #125545 EPOETIN ALFA-EPBX HOSPIRA INC<br />
5/15/<strong>2018</strong> BENDAMUSTINE<br />
BENDAMUSTINE HYDROCHLORIDE Type 5 - New Formulation or New Manufacturer Standard EAGLE PHARMS<br />
HYDROCHLORIDENDA #205580<br />
5/16/<strong>2018</strong> LUCEMYRANDA #209229 LOFEXIDINE HYDROCHLORIDE Type 1 - New Molecular Entity Priority US WORLDMEDS LLC<br />
5/17/<strong>2018</strong> AIMOVIGBLA #761077 ERENUMAB-AOOE AMGEN INC<br />
5/18/<strong>2018</strong> LOKELMANDA #207078 SODIUM ZIRCONIUM CYCLOSILICATE Type 1 - New Molecular Entity Standard ASTRAZENECA PHARMS<br />
5/21/<strong>2018</strong> DOPTELETNDA #210238 AVATROMBOPAG MALEATE Type 1 - New Molecular Entity Priority AKARX INC<br />
5/22/<strong>2018</strong> YONSANDA #210308 ABIRATERONE ACETATE Type 5 - New Formulation or New Manufacturer Standard SUN PHARMA GLOBAL<br />
5/24/<strong>2018</strong> PROGRAFNDA #210115 TACROLIMUS Type 3 - New Dosage Form Standard ASTELLAS<br />
5/24/<strong>2018</strong> HALOBETASOL PROPIONATENDA #210566 HALOBETASOL PROPIONATE Type 3 - New Dosage Form and Type 4 - New Combination Standard THERAPS INC<br />
5/24/<strong>2018</strong> PALYNZIQBLA #761079 PEGVALIASE-PQPZ BIOMARIN PHARM<br />
5/29/<strong>2018</strong> IMVEXXYNDA #208564 ESTRADIOL Type 5 - New Formulation or New Manufacturer Standard THERAPEUTICSMD INC<br />
5/31/<strong>2018</strong> OLUMIANTNDA #207924 BARICITINIB Type 1 - New Molecular Entity Standard ELI LILLY AND CO<br />
5/31/<strong>2018</strong> CONSENSINDA #210045 AMLODIPINE BESYLATE; CELECOXIB Type 4 - New Combination Standard KITOV PHARMS LTD<br />
6/4/<strong>2018</strong> FULPHILABLA #761075 PEGFILGRASTIM-JMDB MYLAN GMBH<br />
6/13/<strong>2018</strong> MOXIDECTINNDA #210867 MOXIDECTIN Type 1 - New Molecular Entity Priority MDGH<br />
6/15/<strong>2018</strong> LYMEPAKNDA #209844 DOXYCYCLINE HYCLATE Type 5 - New Formulation or New Manufacturer Standard CHARTWELL PHARMA<br />
6/21/<strong>2018</strong> NOCDURNANDA #022517 DESMOPRESSIN ACETATE Type 5 - New Formulation or New Manufacturer Standard FERRING PHARMS INC<br />
6/21/<strong>2018</strong> ABLYSINOLNDA #207987 ALCOHOL Type 5 - New Formulation or New Manufacturer Standard BELCHER PHARMS LLC<br />
6/25/<strong>2018</strong> ZEMDRINDA #210303 PLAZOMICIN SULFATE Type 1 - New Molecular Entity Priority ACHAOGEN INC<br />
6/25/<strong>2018</strong> EPIDIOLEXNDA #210365 CANNABIDIOL Type 1 - New Molecular Entity Priority GW RESEARCH LTD<br />
6/27/<strong>2018</strong> BRAFTOVINDA #210496 ENCORAFENIB Type 1 - New Molecular Entity and Type 4 - New Combination Standard ARRAY BIOPHARMA INC<br />
6/27/<strong>2018</strong> MEKTOVINDA #210498 BINIMETINIB Type 1 - New Molecular Entity and Type 4 - New Combination Standard ARRAY BIOPHARMA INC<br />
6/28/<strong>2018</strong> QBREXZANDA #210361 GLYCOPYRRONIUM TOSYLATE Type 3 - New Dosage Form Standard DERMIRA INC<br />
6/28/<strong>2018</strong> NUPLAZIDNDA #210793 PIMAVANSERIN TARTRATE Type 3 - New Dosage Form Standard ACADIA PHARMS INC<br />
6/29/<strong>2018</strong> ARISTADA INITIO KITNDA #209830 ARIPIPRAZOLE LAUROXIL Type 5 - New Formulation or New Manufacturer Standard ALKERMES INC<br />
6/29/<strong>2018</strong> FULVESTRANTNDA #210326 FULVESTRANT Type 5 - New Formulation or New Manufacturer Standard FRESENIUS KABI USA<br />
7/9/<strong>2018</strong> Atropine Injection, 2 mg/0.7 mL, ATROPINE Priority RAFA LABLTD<br />
Single-Dose AutoinjectorNDA #212319<br />
7/10/<strong>2018</strong> VANCOMYCIN HYDROCHLORIDENDA VANCOMYCIN HYDROCHLORIDE Type 5 - New Formulation or New Manufacturer Standard MYLAN LABS LTD<br />
#209481<br />
7/11/<strong>2018</strong> GLYRX-PFNDA #210997 GLYCOPYRROLATE Type 5 - New Formulation or New Manufacturer Standard EXELA PHARMA SCS LLC<br />
7/12/<strong>2018</strong> BORTEZOMIBNDA #209191 BORTEZOMIB Type 5 - New Formulation or New Manufacturer Standard HOSPIRA INC<br />
7/13/<strong>2018</strong> TPOXXNDA #208627 TECOVIRIMAT Type 1 - New Molecular Entity Priority SIGA TECHNOLOGIES INC<br />
7/16/<strong>2018</strong> INFUGEMNDA #208313 GEMCITABINE 0.9%;SODIUM CHLORIDE Type 3 - New Dosage Form Standard SUN PHARM INDS INC<br />
7/17/<strong>2018</strong> SYMTUZANDA #210455 DARUNAVIR;COBICISTAT;EMTRICITAB Type 4 - New Combination Standard JANSSEN PRODS<br />
INE;TENOFOVIR ALAFENAMIDE<br />
7/20/<strong>2018</strong> KRINTAFELNDA #210795 TAFENOQUINE Type 1 - New Molecular Entity Priority GLAXOSMITHKLINE<br />
7/20/<strong>2018</strong> TIBSOVONDA #211192 IVOSIDENIB Type 1 - New Molecular Entity Priority AGIOS PHARMACEUTICALS INC<br />
7/23/<strong>2018</strong> ORILISSANDA #210450 ELAGOLIX SODIUM Type 1 - New Molecular Entity Priority ABBVIE INC<br />
7/24/<strong>2018</strong> DOXERCALCIFEROLNDA #208614 DOXERCALCIFEROL Type 5 - New Formulation or New Manufacturer Standard HOSPIRA INC<br />
7/27/<strong>2018</strong> OMEGAVENNDA #210589 FISH OIL TRIGLYCERIDES Type 1 - New Molecular Entity Priority FRESENIUS KABI USA<br />
7/30/<strong>2018</strong> REMODULINNDA #208276 TREPROSTINIL Type 3 - New Dosage Form Standard UNITED THERAP<br />
7/30/<strong>2018</strong> AZEDRANDA #209607 IOBENGUANE I 131 Type 5 - New Formulation or New Manufacturer Priority PROGENICS PHARMA INC<br />
7/31/<strong>2018</strong> MULPLETANDA #210923 LUSUTROMBOPAG Type 1 - New Molecular Entity Priority SHIONOGI INC<br />
* NDA Submission Classifications<br />
For details, see FDA/CDER MAPP 5018.2<br />
Type 1 New molecular entity<br />
Type 2 New active ingredient<br />
Type 3 New dosage form<br />
Type 4 New combination<br />
Type 5 New formulation or other differences<br />
Type 6 New indication or claim, same applicant [no longer used]<br />
Type 7 Previously marketed but without an approved NDA<br />
Type 8 Rx to OTC<br />
Type 9 New indication or claim, drug not to be marketed under type 9 NDA after approval<br />
Type 10 New indication or claim, drug to be marketed under type 10 NDA after approval<br />
Type 1/4 Type 1, New molecular entity, and Type 4, New combination<br />
Type 2/3 Type 2, New active ingredient, and Type 3, New dosage form<br />
Type 2/4 Type 2, New active ingredient and Type 4, New combination<br />
Type 3/4 Type 3, New Dosage Form, and Type 4, New combination<br />
** Review Priority<br />
Priority:<br />
Review designation assigned to applications for drugs that treat serious conditions and provide significant improvements in<br />
the safety or effectiveness of the treatment, diagnosis, or prevention of serious conditions compared to available therapies<br />
Standard:<br />
Review designation assigned to applications for drugs that do not meet the priority review designation criteria<br />
<strong>The</strong> Official Publication of the Texas Society of Health-System <strong>Pharmacist</strong>s – R&E Foundation